From Mechanisms to Therapy in Neurodegeneration
Spurred on by the success of first TN2 conference held in 2013, the 2015 edition of TN2 conference will again bring together fundamental and clinical research in the field of dementia. However, this time we will go one step further in translating new fundamental insights into treatment by bringing together academic and industrial partners. Partnership between academia and industry is essential for bringing fundamental research findings towards effective drug therapies and/or disease-monitoring diagnostic tools.
Alike the previous TN2 conference we will provide a platform for young talent to present their findings and invite established international researchers to give an overview of the current state-of-the-art in the field.
The 2nd TN2 conference will cover both preclinical and clinical aspects of dementia and connect academia with industrial partners. This conference will be of interest to preclinical and clinical researchers of all academic levels, business developers, and representatives from small-, medium-, and large-sized companies. Together, the 2nd TN2 conference will not only bring state-of-the-art science in dementia in the spotlight, but also provides an excellent opportunity for both academia and industrial partners to explore new collaborations and insights.